2Xideas AG decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 57.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 25,455 shares of the medical research company's stock after selling 33,812 shares during the period. 2Xideas AG's holdings in Agilent Technologies were worth $3,420,000 as of its most recent filing with the SEC.
A number of other hedge funds have also bought and sold shares of the company. Sienna Gestion increased its stake in Agilent Technologies by 29.8% during the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company's stock valued at $10,537,000 after purchasing an additional 17,991 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Agilent Technologies by 8.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company's stock valued at $4,554,000 after buying an additional 2,664 shares during the last quarter. S.E.E.D. Planning Group LLC raised its stake in Agilent Technologies by 12.7% during the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company's stock worth $5,721,000 after acquiring an additional 4,805 shares during the period. Daiwa Securities Group Inc. lifted its holdings in Agilent Technologies by 16.0% in the fourth quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company's stock worth $6,621,000 after acquiring an additional 6,802 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its stake in Agilent Technologies by 9.8% in the fourth quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock valued at $5,892,000 after acquiring an additional 3,915 shares during the period.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on A. Citigroup increased their price target on Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research report on Thursday, February 27th. TD Cowen raised their target price on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Thursday. Barclays lowered their price target on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research report on Thursday. Finally, StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $146.25.
Get Our Latest Stock Analysis on A
Agilent Technologies Price Performance
Shares of NYSE A traded up $2.55 during mid-day trading on Friday, reaching $102.50. 1,169,939 shares of the company traded hands, compared to its average volume of 1,845,030. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $155.35. The firm has a market cap of $29.22 billion, a PE ratio of 23.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.19. The stock has a fifty day simple moving average of $124.64 and a 200-day simple moving average of $134.18. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.
Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.
Agilent Technologies Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies's payout ratio is 22.76%.
Insider Buying and Selling
In related news, Director Daniel K. Podolsky sold 1,819 shares of the company's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares in the company, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,638 shares of company stock worth $731,229 in the last three months.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
